Veru (VERU US)

Analysis

Consumer Staples • United States

Veru Inc. is a revenue generating oncology and urology biopharmaceutical company developing medicines for prostate cancer treatment and prostate cancer supportive care as well as urology specialty pharmaceuticals. Veru Inc. was founded in 1996 and is headquartered in Miami, Florida with offices in London UK and Kuala Lumpur, Malyasia.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00